By Angela Kelly Panel Discusses Treatment Options for Newly Diagnosed C. difficile May 22, 2018 [MD Magazine] Fidaxomicin is a relatively new C. diff drug, approved for the treatment of Clostridium difficile in 2011. It is equally effective as the antibiotic vancomycin; however, it significantly reduces the rate of recurrent …
Our friends at the Antimicrobials Working Group (AWG), an industry led non-profit focused on increasing innovations in infectious disease treatments, are launching an “AMR Stories” initiative. The initiative will tell the story of antimicrobial resistance (AMR) from the perspective of patients, caregivers, providers and researchers. This is a great opportunity …
By Angela Kelly Clostridium Difficile Toxin B Discovery May Lead to Novel Anti-Cancer Drugs May 11, 2018 [ScienceDaily] Researchers from the University of California, Irvine and Harvard University “have discovered how the Clostridium difficile toxin B (TcdB) recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells …
By William J. Beerman, Sr. I recently had the opportunity to present gubernatorial candidate and New Mexico Congresswoman Michelle Lujan Grisham (D-Albuquerque) with information about the Make C. diff Count campaign being waged by the Peggy Lillis Foundation. PLF is concerned that many cases of Clostridium difficile (C. diff) go unreported, …
By Brenna Darazs I think we can all agree that talking about poop isn’t suitable dinner conversation. It’s rarely considered suitable conversation in any setting. Nobody wants to hear about your bowel movements. Well, almost nobody. There are nurses, pharmacists and doctors who actually want to know about your Clostridium …
